Lisdexamfetamine
CAS 608137-32-3 2 FDA-DMF suppliersSmall Molecule
Overview
Lisdexamfetamine is a prodrug of the central nervous system (CNS) stimulant d-amphetamine. It is prescribed primarily for the treatment of ADHD and is designed to decrease potential for abuse.
Therapeutic areas
Attention Deficit Hyperactivity Disorder (ADHD)Binge Eating Disorder
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.